Skip to content
Wednesday, November 18, 2026
North Insight

Users Stopping Weight-Loss Medications Put On Weight Four Times Faster Than Those on Conventional Diets

Illustration of medical syringe and weighing machine
Obesity treatment often requires long-term strategies.

New research suggests that individuals who come off new weight-loss injections like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise regimens.

Research printed in a major health publication demonstrates that while obese people frequently drop a large proportion of their total mass while using the jabs, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.

"People purchasing these medications need to be aware of the risk of quick weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb.

That rate of recovery means a return to pre-treatment weight in about one and a half years.

Weighing Treatments

The study, which looked at 37 of trials involving over 9,000 of participants, contrasted the effects of the injectable medications with other pills.

Researchers note that individuals who shed pounds through diet and exercise generally see a more gradual weight regain—perhaps 0.1 kg a month—after stopping.

Explaining the Fast Regain

Experts suggest the mechanism of the drugs accounts for the heightened weight return.

These medications imitate a body's own chemical called glucagon-like peptide-1, which controls appetite.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the system to generate a reduced amount of its own natural GLP-1, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Stopping of this hormone supplement leads to hunger is no longer kept in check, making excessive eating a significant risk."

An Ongoing Issue?

Health authorities suggest the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.

A number of clinicians contend that, due to the significant potential of relapse, the treatment might need to be long-term.

This view is echoed by pharmaceutical companies, who note that the results "emphasize the persistent character of excess weight," akin to managing diseases like hypertension.

User Testimonies

Individuals who have come off the jabs describe a intense return of appetite.

"It was like a trigger activating and you become extremely hungry," described one woman.

This difficulty is compounded if users have not adopted lasting dietary or behavioural modifications during treatment.

Significant Adoption

Recent estimates indicate that millions of people in the UK have tried weight-loss jabs in the last 12 months, with demand being substantial.

  • Use is more common among females compared to males.
  • The 40s and 50s demographic shows the greatest level of interest.
  • Many obtain the drugs through private healthcare rather than the NHS.

Ultimately, clinicians emphasize that while these medications are potent tools for shedding pounds, they are not a standalone solution and maintained weight loss hinges on integrated behavioural management.

WM
Written by

William Miller

Emily Townsend is a seasoned business journalist with over a decade covering UK market dynamics and tech innovations.

North Insight

Type to search articles.